For reprint rights or to purchase a copy of your Daily Journal photo, email Jeremy_Ellis@dailyjournal.com for prices or call 213-229-5424.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Real Estate/Development

May 24, 2017

Aspyrian Therapeutics moves into Coast 9 in Sorrento Valley

Ted Jacobs of Cushman & Wakefield's San Diego office represented the tenant in the lease transaction. Rancho Bernardo-based BioMed Realty, now a subsidiary of Blackstone Group (NYSE: BGX), represented itself.

Aspyrian Therapeutics, a privately funded clinical stage biotech, moved into 20,074 square feet in Sorrento Valley, Cushman & Wakefield announced Tuesday.

The company's new headquarters are in Coast 9, a nine-building Class A life sciences campus owned by BioMed Realty.

Ted Jacobs of Cushman & Wakefield's San Diego office represented the tenant in the lease transaction.

Rancho Bernardo-based BioMed Realty, now a subsidiary of Blackstone Group (NYSE: BGX), represented itself....

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.